Related Experiment Video
Updated: May 2, 2026

Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
Relations between cognitive status and medication adherence in patients treated for memory disorders
Raymond L Ownby1, Christopher Hertzog2, Sara J Czaja3
1Nova Southeastern University, Fort Lauderdale, Florida.
Ensuring medication adherence in elderly individuals with memory problems is crucial. High adherence to cholinesterase medications appears to maintain cognitive function, while cognitive status does not generally predict adherence.
Area of Science:
- Gerontology
- Neuroscience
- Pharmacology
Background:
- Medication adherence is vital for elderly health, with non-adherence linked to poorer health outcomes.
- Memory problems in the elderly often require long-term medication management.
- Cholinesterase inhibitors are commonly prescribed for cognitive impairment.
Purpose of the Study:
- To investigate the relationship between medication adherence and cognitive status over time in elderly patients.
- To determine if adherence to cholinesterase medications influences cognitive function.
- To assess the predictive power of cognitive status on medication adherence.
Main Methods:
- A longitudinal study involving 27 elderly participants (71-92 years) with memory problems.
- Participants were assigned to control or treatment groups receiving interventions to promote adherence.
- Medication adherence was monitored electronically, and cognitive status was assessed at 3-month intervals over 3.5 years.
- Partial least squares path modeling was used to analyze the temporal relationships.
Main Results:
- Medication adherence significantly predicted cognitive status at subsequent time points.
- Cognitive status did not generally predict medication adherence.
- The study highlights a unidirectional relationship where adherence impacts cognition.
Conclusions:
- Interventions promoting high medication adherence may be essential for preserving cognitive function in the elderly.
- Maintaining adherence to cholinesterase inhibitors is a potential strategy for managing cognitive decline.
- Future research should focus on optimizing adherence strategies in geriatric populations.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Related Concept Videos
Drug Therapy
Antianxiety Medications
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drug Dosing: Geriatric Patients
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood
Pharmacodynamics in Geriatric Patients: Effects of Age